Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device Insertion

IUCD Complication Clinical Trial

Official title:
Clinical Outcomes of Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device Insertion in Women Delivered Only by Cesarean Delivery: a Randomized Double Blinded Clinical Trial

Status Completed

Clinical Trial Summary

To investigate whether vaginal isonicotinic acid hydrazide administered before intrauterine device (IUD) insertion reduces failed insertions, insertion-related complications and pain in in Women Delivered Only by Cesarean Delivery.

Clinical Trial Description

Women may experience pain and technical difficulties may be encountered when insertion of an intrauterine device is attempted through a narrow cervical canal. intrauterine device insertion- related complications and side effects are more common among women who had never delivered vaginally. ;

Study Design

Related Conditions & MeSH terms

IUCD Complication

Clinical Trial Details

NCT number	NCT04499989
Study type	Interventional
Source	Aswan University Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	September 1, 2020
Completion date	August 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04517890` - Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System	N/A
Not yet recruiting	`NCT04505943` - Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion	N/A
Not yet recruiting	`NCT04500002` - Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol Versus Misoprostol Alone in Missed Abortion	N/A
Completed	`NCT04505657` - Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography	N/A
Completed	`NCT04500015` - Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion	Phase 4
Not yet recruiting	`NCT04505917` - Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women	N/A
Completed	`NCT04500028` - Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System	Phase 4